Cargando…

Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2

BACKGROUND: To increase the uptake of evidence-based treatments for hepatitis C (HCV), the Department of Veterans Affairs (VA) established the Hepatitis Innovation Team (HIT) Collaborative. Teams of providers were tasked with choosing implementation strategies to improve HCV care. The aim of the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogal, Shari S., Yakovchenko, Vera, Waltz, Thomas J., Powell, Byron J., Gonzalez, Rachel, Park, Angela, Chartier, Maggie, Ross, David, Morgan, Timothy R., Kirchner, JoAnn E., Proctor, Enola K., Chinman, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454775/
https://www.ncbi.nlm.nih.gov/pubmed/30961615
http://dx.doi.org/10.1186/s13012-019-0881-7
_version_ 1783409609498689536
author Rogal, Shari S.
Yakovchenko, Vera
Waltz, Thomas J.
Powell, Byron J.
Gonzalez, Rachel
Park, Angela
Chartier, Maggie
Ross, David
Morgan, Timothy R.
Kirchner, JoAnn E.
Proctor, Enola K.
Chinman, Matthew J.
author_facet Rogal, Shari S.
Yakovchenko, Vera
Waltz, Thomas J.
Powell, Byron J.
Gonzalez, Rachel
Park, Angela
Chartier, Maggie
Ross, David
Morgan, Timothy R.
Kirchner, JoAnn E.
Proctor, Enola K.
Chinman, Matthew J.
author_sort Rogal, Shari S.
collection PubMed
description BACKGROUND: To increase the uptake of evidence-based treatments for hepatitis C (HCV), the Department of Veterans Affairs (VA) established the Hepatitis Innovation Team (HIT) Collaborative. Teams of providers were tasked with choosing implementation strategies to improve HCV care. The aim of the current evaluation was to assess how site-level implementation strategies were associated with HCV treatment initiation and how the use of implementation strategies and their association with HCV treatment changed over time. METHODS: A key HCV provider at each VA site (N = 130) was asked in two consecutive fiscal years (FYs) to complete an online survey examining the use of 73 implementation strategies organized into nine clusters as described by the Expert Recommendations for Implementing Change (ERIC) study. The number of Veterans initiating treatment for HCV, or “treatment starts,” at each site was captured using national data. Providers reported whether the use of each implementation strategy was due to the HIT Collaborative. RESULTS: Of 130 sites, 80 (62%) responded in Year 1 (FY15) and 105 (81%) responded in Year 2 (FY16). Respondents endorsed a median of 27 (IQR19–38) strategies in Year 2. The strategies significantly more likely to be chosen in Year 2 included tailoring strategies to deliver HCV care, promoting adaptability, sharing knowledge between sites, and using mass media. The total number of treatment starts was significantly positively correlated with total number of strategies endorsed in both years. In Years 1 and 2, respectively, 28 and 26 strategies were significantly associated with treatment starts; 12 strategies overlapped both years, 16 were unique to Year 1, and 14 were unique to Year 2. Strategies significantly associated with treatment starts shifted between Years 1 and 2. Pre-implementation strategies in the “training/educating,” “interactive assistance,” and “building stakeholder interrelationships” clusters were more likely to be significantly associated with treatment starts in Year 1, while strategies in the “evaluative and iterative” and “adapting and tailoring” clusters were more likely to be associated with treatment starts in Year 2. Approximately half of all strategies were attributed to the HIT Collaborative. CONCLUSIONS: These results suggest that measuring implementation strategies over time is a useful way to catalog implementation of an evidence-based practice over time and across settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-019-0881-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6454775
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64547752019-04-19 Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2 Rogal, Shari S. Yakovchenko, Vera Waltz, Thomas J. Powell, Byron J. Gonzalez, Rachel Park, Angela Chartier, Maggie Ross, David Morgan, Timothy R. Kirchner, JoAnn E. Proctor, Enola K. Chinman, Matthew J. Implement Sci Research BACKGROUND: To increase the uptake of evidence-based treatments for hepatitis C (HCV), the Department of Veterans Affairs (VA) established the Hepatitis Innovation Team (HIT) Collaborative. Teams of providers were tasked with choosing implementation strategies to improve HCV care. The aim of the current evaluation was to assess how site-level implementation strategies were associated with HCV treatment initiation and how the use of implementation strategies and their association with HCV treatment changed over time. METHODS: A key HCV provider at each VA site (N = 130) was asked in two consecutive fiscal years (FYs) to complete an online survey examining the use of 73 implementation strategies organized into nine clusters as described by the Expert Recommendations for Implementing Change (ERIC) study. The number of Veterans initiating treatment for HCV, or “treatment starts,” at each site was captured using national data. Providers reported whether the use of each implementation strategy was due to the HIT Collaborative. RESULTS: Of 130 sites, 80 (62%) responded in Year 1 (FY15) and 105 (81%) responded in Year 2 (FY16). Respondents endorsed a median of 27 (IQR19–38) strategies in Year 2. The strategies significantly more likely to be chosen in Year 2 included tailoring strategies to deliver HCV care, promoting adaptability, sharing knowledge between sites, and using mass media. The total number of treatment starts was significantly positively correlated with total number of strategies endorsed in both years. In Years 1 and 2, respectively, 28 and 26 strategies were significantly associated with treatment starts; 12 strategies overlapped both years, 16 were unique to Year 1, and 14 were unique to Year 2. Strategies significantly associated with treatment starts shifted between Years 1 and 2. Pre-implementation strategies in the “training/educating,” “interactive assistance,” and “building stakeholder interrelationships” clusters were more likely to be significantly associated with treatment starts in Year 1, while strategies in the “evaluative and iterative” and “adapting and tailoring” clusters were more likely to be associated with treatment starts in Year 2. Approximately half of all strategies were attributed to the HIT Collaborative. CONCLUSIONS: These results suggest that measuring implementation strategies over time is a useful way to catalog implementation of an evidence-based practice over time and across settings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13012-019-0881-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-08 /pmc/articles/PMC6454775/ /pubmed/30961615 http://dx.doi.org/10.1186/s13012-019-0881-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Rogal, Shari S.
Yakovchenko, Vera
Waltz, Thomas J.
Powell, Byron J.
Gonzalez, Rachel
Park, Angela
Chartier, Maggie
Ross, David
Morgan, Timothy R.
Kirchner, JoAnn E.
Proctor, Enola K.
Chinman, Matthew J.
Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title_full Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title_fullStr Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title_full_unstemmed Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title_short Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2
title_sort longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis c treatment: year 2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454775/
https://www.ncbi.nlm.nih.gov/pubmed/30961615
http://dx.doi.org/10.1186/s13012-019-0881-7
work_keys_str_mv AT rogalsharis longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT yakovchenkovera longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT waltzthomasj longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT powellbyronj longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT gonzalezrachel longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT parkangela longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT chartiermaggie longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT rossdavid longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT morgantimothyr longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT kirchnerjoanne longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT proctorenolak longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2
AT chinmanmatthewj longitudinalassessmentoftheassociationbetweenimplementationstrategyuseandtheuptakeofhepatitisctreatmentyear2